Search By Initial

Name Index R

• (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate (Catalog# : 2062334, Cas# : 2161337-98-8)
• (R)-methyl 2-(tert-butyldimethylsilyloxy)propanoate (Catalog# : 202329, Cas# : 171230-81-2)
• 3-[(2RS)-tetrahydro-2H-pyran-2-yloxy]propanoic acid (Catalog# : 2062017, Cas# : 1221443-23-7)
• ((1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl)methyl acetate (Catalog# : 2062004, Cas# : 1369768-29-5)
• Rigosertib (Catalog# : 690120, Cas# : 592542-59-1)Rigosertib(ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, w
• Resatorvid (Catalog# : 206102, Cas# : 243984-11-4)Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b
• RU320521 (Catalog# : 204503, Cas# : 2262452-06-0)RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in
• (R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate (Catalog# : 580586, Cas# : 2086689-88-3)(R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate, CAS 2086689-88-3, is a v
• Remetinostat (Catalog# : 193111, Cas# : 946150-57-8)Remetinostat, also known as SHP-141, is a topical formulation containing the histone
• RG7834 (Catalog# : 19355, Cas# : 2072057-17-9)RG7834，also known as RO7020322, is a novel oral HBV viral gene expression inhibitor
• RWJ-56110 (Catalog# : 19353, Cas# : 252889-88-6)RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t
• RBC8 (Catalog# : 19313, Cas# : 361185-42-4)RBC8 is a RalA and RalB GTPase inhibitor (EC50 ~3.5 μM). RBC8 suppresses growth of x
• Rogaratinib (Catalog# : 192277, Cas# : 1443530-05-9)Rogaratinib, also known as BAY-1163877, is an aberrant fibroblast growth factor recep
• Rebimastat (Catalog# : 192254, Cas# : 259188-38-0)Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m
• Retosiban (Catalog# : 192193, Cas# : 820957-38-8)Retosiban, also known as GSK-221149-A; is an oral active, potent and selective, sub-n
• RKI-1313 (Catalog# : 19183, Cas# : 1342276-76-9)RKI-1313 Negative control for RKI-1447 (GLXC-05200) which is a potent inhibitor of th
• RGX-104 free form (Catalog# : 19181, Cas# : 610318-54-2)RGX-104, also known as SB 742881, is a liver X receptor beta agonist with potential i
• R547 (Catalog# : 1811151, Cas# : 741713-40-6)R547 is orally bioavailable diaminopyrimidine cyclin-dependent kinase inhibitor (CDKI
• Regadenoson (Catalog# : 1810224, Cas# : 313348-27-5)Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that
• RMC-4550 (Catalog# : 186251, Cas# : 2172651-73-7)RMC-4550 is a potent and selective SHP2 inhibitor.
• RGX-104 HCl (Catalog# : 186234, Cas# : 610318-03-1)RGX-104 is a liver X receptor beta agonist with potential immunomodulating and antine
• Resminostat HCl (Catalog# : 185317, Cas# : 1187075-34-8)Resminostat HCl is a potent inhibitor of HDAC1/3/6.
• Rovazolac (Catalog# : 185234, Cas# : 1454288-88-0)Rovazolac is an anti-inflammatory drug candidate.
• Rolapitant free base (Catalog# : 185152, Cas# : 5552292-08-7)Rolapitant, also known as SCH-619734, is an orally bioavailable, centrally-acting, se
• RO10-5824 (Catalog# : 185141, Cas# : 189744-46-5)RO10-5824 is a D4-selective partial agonist. RO10-5824 is a potent candidate for the
• Ricasetron (Catalog# : 184281, Cas# : 117086-68-7)Ricasetron, also known as Brl 46470, is antiemetic and axiolytic.
• R-IMPP (Catalog# : 18413, Cas# : 2133832-83-2)R-IMPP is an inhibitor of PCSK9 translation.
• Rimegepant (Catalog# : 18441, Cas# : 1289023-67-1)Rimegepant, aslo known as BMS-927711, is a potent, selective, competitive and orally
• Ritlecitinib ( PF-06651600 ) (Catalog# : 18435, Cas# : 1792180-81-4)Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a
• R-GNE-140 (Catalog# : 18432, Cas# : 2003234-63-5)R-GNE-140 a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDH